Selected Grants
Priovant BREPO
Clinical TrialPrincipal Investigator · Awarded by Priovant Therapeutics, Inc · 2022 - 2027PRA-Ionis ATTR-CM
Clinical TrialPrincipal Investigator · Awarded by Ionis Pharmaceuticals Inc · 2020 - 2026A PROGRAM OF THREE STUDIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical TrialPrincipal Investigator · Awarded by Parexel International LLC · 2021 - 2026CMS Linkage
ResearchPrincipal Investigator · Awarded by Bristoll Myers Squibb · 2020 - 2025Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2025Priovant BREPO
Clinical TrialPrincipal Investigator · Awarded by Priovant Therapeutics, Inc · 2022 - 2027PRA-Ionis ATTR-CM
Clinical TrialPrincipal Investigator · Awarded by Ionis Pharmaceuticals Inc · 2020 - 2026A PROGRAM OF THREE STUDIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical TrialPrincipal Investigator · Awarded by Parexel International LLC · 2021 - 2026CMS Linkage
ResearchPrincipal Investigator · Awarded by Bristoll Myers Squibb · 2020 - 2025Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2025Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation
ResearchCo Investigator · Awarded by University of Texas Southwestern Medical Center · 2022 - 2025PERFORM- TSIX
Clinical TrialPrincipal Investigator · Awarded by Roche Diagnostics · 2022 - 2025AUGUSTUS_Extension
ResearchPrincipal Investigator · Awarded by Bristol-Myers Squibb Company · 2021 - 2024Regeneron 20118
Clinical TrialPrincipal Investigator · Awarded by Regeneron Pharmaceuticals, Inc. · 2021 - 2024Prostate Cancer and Cardiovascular Disease: Principles of Optimal Multidisciplinary Management in Clinical Practice
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by International Cardio-Oncology Society, Inc. · 2022 - 2024GSK Vaccine Program
Clinical TrialPrincipal Investigator · Awarded by GlaxoSmithKline Biologicals SA · 2024 - 20241/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
ResearchCo Investigator · Awarded by National Institutes of Health · 2023 - 2024MACE COMMITTEE COLLABORATION LOI
Clinical TrialPrincipal Investigator · Awarded by GlaxoSmithKline · 2020 - 2023Bayer-21170-RE-THINc
Clinical TrialPrincipal Investigator · Awarded by Bayer Healthcare Pharmaceuticals Inc · 2020 - 2023Bayer-20115-CONVERT
Clinical TrialPrincipal Investigator · Awarded by Bayer Healthcare Pharmaceuticals Inc · 2020 - 2022H9X-MC-GBGO
Clinical TrialPrincipal Investigator · Awarded by Eli Lilly and Company · 2020 - 2022Omecamtiv Mecarbil in Heart Failure
Clinical TrialPrincipal Investigator · Awarded by Cytokinetics, Inc. · 2018 - 2022AF Detection, Diagnosis and Drug Therapy EDucational Program (AF-4Ds)
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by THE AAD · 2021 - 2021Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2021Trial to Assess Chelation Therapy 2 (TACT2) Data Coordinating Center
Clinical TrialCEC Director · Awarded by National Institutes of Health · 2015 - 2020GSK-CKD program_CEC
Clinical TrialPrincipal Investigator · Awarded by GlaxoSmithKline · 2017 - 2020DCRI-Stanford CEC Summit
ConferencePrincipal Investigator · Awarded by Baim Institute for Clinical Research · 2018 - 2020DCRI-Stanford Symposium
ConferencePrincipal Investigator · Awarded by AG Mednet · 2018 - 2020DCRI-Stanford CEC Summit
ConferencePrincipal Investigator · Awarded by WIRB-Copernicus Group · 2018 - 2020DCRI-Stanford Symposium
ConferencePrincipal Investigator · Awarded by Language Scientific, Inc. · 2018 - 2020A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, PK, and PD Effects of REGN2477-1033 in Obese Patients with Type 2 Diabetes Mellitus
Clinical TrialPrincipal Investigator · Awarded by Regeneron Pharmaceuticals, Inc. · 2018 - 2020Sanofi SOTA Outcomes EFC15156
Clinical TrialPrincipal Investigator · Awarded by Lexicon Pharmaceuticals · 2018 - 2020Lilly GPGB Diabetes Study
Clinical TrialPrincipal Investigator · Awarded by Eli Lilly and Company · 2017 - 2019AMG785-2015242
Clinical TrialPrincipal Investigator · Awarded by Amgen, Inc. · 2017 - 2018HeartRescue Brazil (RAPIDO)
ResearchPrincipal Investigator · Awarded by Research Triangle Institute International · 2016 - 2018CEC Adjudications for Lilly GIP_GLP1
Clinical TrialPrincipal Investigator · Awarded by Eli Lilly and Company · 2017 - 2018a retrospective re-review of all negatively adjudicated events (NAE) across three (3) protocols/studies
Clinical TrialPrincipal Investigator · Awarded by Amgen, Inc. · 2018 - 2018Educational Preceptorship Agreement
ConferencePrincipal Investigator · Awarded by Pfizer, Inc. · 2017 - 2018Bacteremia Modification 14
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2009 - 2017Mod 11 for Option 3 - Staphylococcal Bacteremia Study
Clinical TrialInvestigator · Awarded by National Institutes of Health · 2009 - 2017Modification No 13 Staphylococcal Bacteremia Study
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2009 - 2017GBGJ Dulaglutide_CEC
Clinical TrialPrincipal Investigator · Awarded by Eli Lilly and Company · 2016 - 2017Modification No. 8 - Staphylococcal Bacteremia Study
Clinical TrialInvestigator · Awarded by National Institutes of Health · 2009 - 2016External Relationships
- Bayer
- Bristol Myers Squibb
- GlaxoSmithKline
- Novo Nordisk
- Pfizer Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.